IGC Pharma Balance Sheet
IGC Pharma's total assets for Q3 2026 were $9.71M, a decrease of -0.32% from the previous quarter. IGC total liabilities were $2.29M for the fiscal quarter, a 38.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.